On plans that kept the drug, Aetna's current policy (6947-C, P04-2025 revision) grants weight-loss authorization when all of the following hold: You have "participated in a comprehensive weight management program that encourages behavioral modification, reduced-calorie diet, AND increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy." Your baseline BMI is 30 or higher or 27 or higher with at least one weight-related comorbid condition (the policy's examples: hypertension, type 2 diabetes, dyslipidemia)
If you take diabetes medications, blood thinners, or other prescription drugs, consult your healthcare provider before using this or any supplement to discuss potential interactions
For context, the GHK-Cu copper peptide another compound with a strong preclinical profile faces similar evidence constraints
demonstrated that GLP-1RAs can drastically lower visceral fat and hepatic fat content in adults
Tarrago, L
By helping people limit compulsive eating and drinking, motivate movement, and reduce chronic inflammation, which we know GLP-1s can do, we promote a higher quality life. The latest science demonstrates that we should be thinking about GLP-1 medication differently, said Dr